|
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
|
journal
|
May 2012 |
|
Pharmaceutical Development and Regulatory Considerations for Nanoparticles and Nanoparticulate Drug Delivery Systems
|
journal
|
November 2013 |
|
Hydrolysis of Saturated Soybean Phosphatidylcholine in Aqueous Liposome Dispersions
|
journal
|
April 1993 |
|
Chemical Hydrolysis of Phospholipids
|
journal
|
September 1995 |
|
Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids
|
journal
|
November 1995 |
|
Liposomal drug delivery systems: From concept to clinical applications
|
journal
|
January 2013 |
|
Self-assembling peptide-based building blocks in medical applications
|
journal
|
February 2017 |
|
Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition
|
journal
|
February 2006 |
|
A synthetic method for peptide-PEG-lipid conjugates: Application of Octreotide-PEG-DSPE synthesis
|
journal
|
August 2008 |
|
A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
|
journal
|
November 2010 |
|
A BH3 Mimetic for Killing Cancer Cells
|
journal
|
June 2016 |
|
Liposomal drug formulations in cancer therapy: 15 years along the road
|
journal
|
February 2012 |
|
Peptide therapeutics: Targeting the undruggable space
|
journal
|
April 2015 |
|
Ligand-targeted liposome design: challenges and fundamental considerations
|
journal
|
January 2014 |
|
Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide
|
journal
|
March 2007 |
|
The evolving landscape of drug products containing nanomaterials in the United States
|
journal
|
April 2017 |
|
Molecular engineering solutions for therapeutic peptide delivery
|
journal
|
January 2017 |
|
The Future of Peptide-based Drugs
|
journal
|
December 2012 |
|
Challenges in Development of Targeted Liposomal Therapeutics
|
journal
|
March 2012 |
|
Lipid-Core Micelles for Targeted Drug Delivery
|
journal
|
October 2005 |
|
Multifunctionality of lipid-core micelles for drug delivery and tumour targeting
|
journal
|
October 2010 |
|
Peptides as Targeting Elements and Tissue Penetration Devices for Nanoparticles
|
journal
|
May 2012 |
|
Pharmaceutical Development and Regulatory Considerations for Nanoparticles and Nanoparticulate Drug Delivery Systems
|
journal
|
November 2013 |
|
Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery Systems
|
journal
|
January 2014 |
|
Hydrolysis of Saturated Soybean Phosphatidylcholine in Aqueous Liposome Dispersions
|
journal
|
April 1993 |
|
Chemical Hydrolysis of Phospholipids
|
journal
|
September 1995 |
|
Peptide delivery using phospholipid micelles
|
journal
|
July 2012 |
|
Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids
|
journal
|
November 1995 |
|
Liposomal drug delivery systems: From concept to clinical applications
|
journal
|
January 2013 |
|
Self-assembling peptide-based building blocks in medical applications
|
journal
|
February 2017 |
|
Effects of phospholipid hydrolysis on the aggregate structure in DPPC/DSPE-PEG2000 liposome preparations after gel to liquid crystalline phase transition
|
journal
|
February 2006 |
|
A synthetic method for peptide-PEG-lipid conjugates: Application of Octreotide-PEG-DSPE synthesis
|
journal
|
August 2008 |
|
A Stapled p53 Helix Overcomes HDMX-Mediated Suppression of p53
|
journal
|
November 2010 |
|
A BH3 Mimetic for Killing Cancer Cells
|
journal
|
June 2016 |
|
Liposomal drug formulations in cancer therapy: 15 years along the road
|
journal
|
February 2012 |
|
Peptide therapeutics: current status and future directions
|
journal
|
January 2015 |
|
Peptide therapeutics: Targeting the undruggable space
|
journal
|
April 2015 |
|
Ligand-targeted liposome design: challenges and fundamental considerations
|
journal
|
January 2014 |
|
Effect of pH, ionic strength and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions
|
journal
|
November 2000 |
|
Reactivation of the p53 Tumor Suppressor Pathway by a Stapled p53 Peptide
|
journal
|
March 2007 |
|
The evolving landscape of drug products containing nanomaterials in the United States
|
journal
|
April 2017 |
|
Molecular engineering solutions for therapeutic peptide delivery
|
journal
|
January 2017 |
|
The Future of Peptide-based Drugs
|
journal
|
December 2012 |
|
Challenges in Development of Targeted Liposomal Therapeutics
|
journal
|
March 2012 |
|
Lipid-based carriers: manufacturing and applications for pulmonary route
|
journal
|
June 2012 |
|
Lipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
|
journal
|
January 2009 |
|
Lipid-Core Micelles for Targeted Drug Delivery
|
journal
|
October 2005 |
|
Multifunctionality of lipid-core micelles for drug delivery and tumour targeting
|
journal
|
October 2010 |
|
Advances and Challenges of Liposome Assisted Drug Delivery
|
journal
|
December 2015 |